PTK2B and lung carcinoma: The application of siRNA-PyK2 decreased the invasion of A549 lung cancer cells [84], and the down-regulation of tropomyosin-related kinase B attenuated PyK2 phosphorylation (Y402) and subsequently decreased A549 migration [84].